Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Novavax Inc (NQ: NVAX )

12.20 -4.22 (-25.70%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 30, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 22,545,240
Open 14.44
Bid (Size) 12.18 (2)
Ask (Size) 12.20 (1)
Prev. Close 16.42
Today's Range 11.63 - 14.90
52wk Range 3.532 - 23.86
Shares Outstanding 74,484,166
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
JPMorgan Just Issued a Warning on Novavax (NVAX) Stock
Novavax has inked a key vaccine deal with Sanofi, but NVAX stock is down after JPMorgan warned about overvaluation concerns. 
Via InvestorPlace
Why Merck Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga

Performance

YTD
+142.54%
+142.54%
1 Month
-4.16%
-4.16%
3 Month
+184.38%
+184.38%
6 Month
+191.17%
+191.17%
1 Year
+31.47%
+31.47%

More News

Read More
Stocks Mixed After Job Openings, Consumer Data
Via Talk Markets
Topics Economy
Exposures Interest Rates
Market Whales and Their Recent Bets on NVAX Options
Via Benzinga
What's Going On With Novavax Shares Today?
Via Benzinga
Lattice Semiconductor Posts Weak Q2 Results, Joins Symbotic, Woodward And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Via Benzinga
Why F5 Shares Are Trading Higher By Over 14%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Looking Into Novavax's Recent Short Interest
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Here's How Much $100 Invested In Novavax 5 Years Ago Would Be Worth Today
Via Benzinga
$100 Invested In This Stock 5 Years Ago Would Be Worth $400 Today
Via Benzinga
(NVAX) - Analyzing Novavax's Short Interest
Via Benzinga
Biotech Bull Market Is Intact But SMIDs Are Too Volatile
Via Talk Markets
COVID Activity Is Elevated Across 26 States In Summer Surge, Biden Remains In Isolation: 3 Vaccine Stocks To Watch
Via Benzinga
Exposures COVID-19
The Lazarus Effect: 3 ‘Dead’ Stocks That Could Rise From the Ashes
Via InvestorPlace
UnitedHealth Posts Better-Than-Expected Earnings, Joins AngioDynamics, Bank of America And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Decoding Novavax's Options Activity: What's the Big Picture?
Via Benzinga
What's Going On With Novavax Shares Monday?
Via Benzinga
Novavax’s Second Act: How a Fallen COVID Star Could Rise from the Ashes
Via InvestorPlace
Exposures COVID-19
Surprise! 3 Stocks That Are Outperforming Nvidia in 2024.
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
Trading SMID Biotech Stocks In A Volatile Market
Via Talk Markets
Where Will Novavax Be in 1 Year?
Via The Motley Fool
Meme Stock or Vaccine Stock? Novavax’s Identity Crisis and Why It Matters for Investors
Via InvestorPlace
Exposures COVID-19 Product Safety
You’ve Been Warned! 3 Biotech Stocks to Buy Now or Regret Forever.
Via InvestorPlace
Intelligent Bio Solutions Inc. (NASDAQ: INBS) Rises in After-Hours Trading Following Major UK Contracts and FDA Progress
Via AB Newswire
Topics Economy
Exposures Product Safety Supply Chain
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

© Copyright 2015, Penticton Herald, Penticton, BC. Powered by BLOX Content Management System from TownNews.com.